Swiss Multi-Family Office Invests in Newronika’s €13.6M Series B

Swiss multi-family office Wille Finance has participated in the €13.6 million Series B funding round of Newronika, a company specializing in deep brain stimulation (DBS) technology. The financing was led by Fondazione ENEA Tech e Biomedical and included contributions from other investors such as Indaco Venture Partners SGR, Innogest SGR, TNBT Capital, and F3F.

Investment in Neuromodulation Technology

Newronika is developing an adaptive DBS system designed to optimize treatment for Parkinson’s disease patients by using real-time neural data and machine learning. The new funding will support further clinical validation and commercialization of this technology, as well as product development and strategic collaborations.

Dr. Lorenzo Rossi, Co-Founder and CEO of Newronika, stated, “This funding round confirms our commitment to improving deep brain stimulation by integrating real-time data processing and machine learning.”

Maria Cristina Porta, General Manager at ENEA Tech e Biomedical, highlighted the potential impact of Newronika’s work, stating, “Their technology represents an important step forward in neuromodulation, and we are pleased to support their efforts.”

About the Swiss multi family office Wille Finance

Wille Finance is a Swiss-based multi-family office that invests in private equity, real estate, and listed assets. The firm’s investment strategy focuses on long-term value creation and partnerships with companies in sectors such as healthcare and technology.

Founded in 2007, Wille Finance has grown into an investment platform with a portfolio of 42 companies and a team of 30 professionals, having over CHF500M assets under management. The firm’s approach emphasizes trust, an entrepreneurial mindset, and long-term commitment to its investments.

Source: Morningstar (18.02.2025)
Picture Source: Planet Volumes (18.02.2025)